Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza. (2020)

First Author: Scott C
Attributed to:  Microbubble Enhanced Imaging and Therapeutic Delivery funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.ppat.1008716

PubMed Identifier: 32780760

Publication URI: http://europepmc.org/abstract/MED/32780760

Type: Journal Article/Review

Volume: 16

Parent Publication: PLoS pathogens

Issue: 8

ISSN: 1553-7366